Crossmark

Development of oxetane modified building blocks for peptide synthesis

Crossref DOI link: https://doi.org/10.1039/D0OB01208D

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Roesner, Stefan https://orcid.org/0000-0003-2143-4708
Beadle, Jonathan D.

Tam, Leo K. B. https://orcid.org/0000-0002-2436-0057
Wilkening, Ina https://orcid.org/0000-0001-7517-0678
Clarkson, Guy J. https://orcid.org/0000-0003-3076-3191
Raubo, Piotr

Shipman, Michael https://orcid.org/0000-0002-3349-5594
Funding

Funding for this research was provided by:

AstraZeneca

University of Warwick

Leverhulme Trust (RPG-2016-355)
License Information

Accepted Manuscript valid from 2021-06-29
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

: Crystal Structure Data

IDENTIFIERS

: Stefan Roesner (ORCID)

: Leo K. B. Tam (ORCID)

: Ina Wilkening (ORCID)

: Guy J. Clarkson (ORCID)

: Michael Shipman (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 12 June 2020; Accepted 29 June 2020; Accepted Manuscript published 29 June 2020; Advance Article published 3 July 2020; Version of Record published 22 July 2020